Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2024-03-18 00:00:00 ET · period of report 2024-03-14 · accession 0001628280-24-011683 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-18 | 2024-03-14 | MYGN | Solaiman Shereen | CHRO | A - Grant | $0.00 | +41.0K | 55.8K | +278% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-14 | A | A | 41,042 | $0.00 | 55,790 | D | — | — |